We are so lucky to live in a world where clinical trials surrounding medical cannabis are happening. Many users turn to medical cannabis as an alternative approach to traditional medicine. Nowadays, it is so easy head to the internet to research the latest clinical trials taking place to receive information and/or do your own research.
The clinical study, identifier NCT05106504, is focused on those with Parkinson’s Disease (Clinical Trials). “Parkinson’s Disease is a progressive nervous system disorder that affects movement. The symptoms start gradually, sometimes starting with a barely noticeable tremor in just one hand. Tremors are common, but the disorder also commonly causes stiffness or slowing of movement. In the early stages of Parkinson’s disease, your face may show little or no expression. Your arms may not swing when you walk. Your speech may become soft or slurred. Parkinson’s disease symptoms worsen as your condition progresses over time. Although Parkinson’s disease can’t be cured, medications might significantly improve your symptoms. Occasionally, your doctor may suggest surgery to regulate certain regions of your brain and improve your symptoms” (Mayo Clinic). This is where many patients turn to medical cannabis to help aide in their treatment.
When researching or participating in clinical studies it is important to remember “the safety and scientific validity of this study is responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating” (ClinicalTrials.Gov)
This specific clinical trial is to prospectively observe patients with Parkinson’s Disease before and after using medical cannabis for non-motor symptoms effect. The study type is observational of 100 male/female participants ranging from 18 years old to 80 years old with a license to use Medical Cannabis for Parkinson’s Disease symptoms. The actual study began on September 2,2021 and is estimated for completion in August 2024. If you are interested in participating in the study please click here to contact the provider. The primary outcome measures stated are “1. Change in Non-motor symptoms scale (NMSS) [ Time Frame: before and 4-8 weeks after treatment initiation ] NMSS will be assessed before and after medical cannabis use, range 0-360, higher scores mean a worse outcome. 2. Change in Bladder over activity symptoms [ Time Frame: before and 4-8 weeks after treatment initiation ] Overactive Bladder Symptom Score (OABSS) questionnaires will be assessed before and after medical cannabis use, range 0-15, higher scores mean a worse outcome” ( Clinical Trials).
We look forward to learning more about the benefits of medical cannabis for those with Parkinson’s Disease and the findings within this clinical trial.